Results 11 to 20 of about 101,889 (202)

Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients

Arthritis Research & Therapy, 2018
Background The aim of this study was to assess the outcomes of remission induction in patients with IgG4-related disease (IgG4-RD) in our cohort, and to investigate the characteristics, prognosis, and risk factors in the patients failed of remission ...
Liwen Wang, Panpan Zhang, Mu Wang, Ruie Feng, Yamin Lai, Linyi Peng, Yunyun Fei, Xuan Zhang, Yan Zhao, Xiaofeng Zeng, Fengchun Zhang, Wen Zhang   +11 more
doaj   +2 more sources

Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis

The Saudi Journal of Gastroenterology, 2017
Background/Aims: Treatment of refractory ulcerative colitis (UC) is a clinical challenge, and after biological therapy, monitoring clinical and endoscopic responses is fundamental.
Elham A Hassan, Haidi K Ramadan, Ali A Ismael, Khaled F Mohamed, Madiha M El-Attar, Ihab Alhelali   +5 more
doaj   +2 more sources

Prediction of response to remission induction therapy by gene expression profiling of peripheral blood in Japanese patients with microscopic polyangiitis [PDF]

Arthritis Research & Therapy, 2017
Background Microscopic polyangiitis (MPA), which is classified as an anti-neutrophil cytoplasmic antibody (ANCA)-associated small vessel vasculitis, is one of the most frequent primary vasculitides in Japan.
Akihiro Ishizu, Utano Tomaru, Sakiko Masuda, Ken-ei Sada, Koichi Amano, Masayoshi Harigai, Yasushi Kawaguchi, Yoshihiro Arimura, Kunihiro Yamagata, Shoichi Ozaki, Hiroaki Dobashi, Sakae Homma, Yasunori Okada, Hitoshi Sugiyama, Joichi Usui, Naotake Tsuboi, Seiichi Matsuo, Hirofumi Makino, for the Research Committee of the Intractable Vasculitis Syndrome and the Research Committee of the Intractable Renal Disease of the Ministry of Health, Labour, and Welfare of Japan   +18 more
doaj   +3 more sources

Probiotics for induction of remission in ulcerative colitis [PDF]

Cochrane Database of Systematic Reviews, 2020
Ulcerative colitis is an inflammatory condition affecting the colon, with an annual incidence of approximately 10 to 20 per 100,000 people. The majority of people with ulcerative colitis can be put into remission, leaving a group who do not respond to first- or second-line therapies.
Kaur, Lakhbir, Gordon, Morris, Baines, Patricia Anne, Iheozor-Ejiofor, Zipporah, Sinopoulou, Vasiliki, Akobeng, Anthony K   +5 more
openaire   +4 more sources

Redefining Remission Induction Chemotherapy Ineligibility by Early Mortality in De Novo Acute Myeloid Leukemia. [PDF]

J Clin Med, 2021
The therapeutic strategies for acute myeloid leukemia (AML) patients ineligible for remission induction chemotherapy have been improving in the past decade. Therefore, it is important to define ineligibility for remission induction chemotherapy.
Li YC, Shih YH, Chen TC, Gau JP, Su YC, Chen MH, Hsu CY, Liao CS, Teng CJ.   +8 more
europepmc   +2 more sources

Vedolizumab for induction and maintenance of remission in Crohn's disease [PDF]

, 2023
Vedolizumab blocks inflammatory activity within the gastrointestinal tract. Systematic reviews have demonstrated the efficacy of vedolizumab in ulcerative colitis and inflammatory bowel disease in general.
Vassiliki Sinopoulou, Samuel Hui, Anuj Krishna, Nik Sheng Ding, Krishna, Anuj, Gordon, Morris, Ghazaleh Aali, Ray K Boyapati, Hui, Samuel, Aali, Ghazaleh, Boyapati, Ray K, Ding, Nik Sheng, Sinopoulou, Vasiliki, Morris Gordon   +13 more
core   +1 more source

Prebiotics for induction of remission in ulcerative colitis [PDF]

, 2022
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the efficacy and safety of prebiotics for the induction of remission in people with active ulcerative ...
Limketkai, Berkeley N, Aali, Ghazaleh, Mullin, Gerard, Akobeng, Anthony K, Sinopoulou, Vasiliki, Gordon, Morris   +5 more
core   +1 more source

Kinetics of human leukocyte antigen receptor HLA-DR⁺ monocytes and T lymphocytes during remission induction therapy in ANCA-associated vasculitis. [PDF]

J Nephrol, 2022
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is characterized by small vessel inflammation and the presence of autoantibodies against cytoplasmic proteases, most often proteinase-3 and myeloperoxidase.
Tampe D, Hakroush S, Biggemann L, Winkler MS, Tampe B.   +4 more
europepmc   +2 more sources

Tofacitinib as induction and maintenance therapy for ulcerative colitis [PDF]

, 2022
Background: Tofacitinib, an oral, small-molecule Janus kinase inhibitor, was shown to have potential efficacy as induction therapy for ulcerative colitis in a phase 2 trial.
Niezychowski, Wojciech, Sands, Bruce E., Lawendy, Nervin, OCTAVE Sustain Investigators., Feagan, Brian G., Panés Díaz, Julià, Mukherjee, Arnab, Su, Chinyu, Reinisch, Walter, D'Haens, Geert R., Friedman, Gary, Healey, Paul, Guardiola, Jordi, Schreiber, Stefan, Danese, Silvio, Sandborn, William J., Yu, Dahong, OCTAVE Induction 2, OCTAVE Induction 1, Woodworth, Deborah, Zhang, Haiying, Vermeire, Séverine   +21 more
core   +1 more source

Glutamine for induction of remission in Crohn's disease [PDF]

Cochrane Database of Systematic Reviews, 2016
Crohn's disease is a chronic relapsing condition of the alimentary tract with a high morbidity secondary to bowel inflammation. Glutamine plays a key role in maintaining the integrity of the intestinal mucosa and has been shown to reduce inflammation and disease activity in experimental models of Crohn's disease.To evaluate the efficacy and safety of ...
Akobeng, Anthony, Elawad, M, Gordon, Morris   +2 more
openaire   +2 more sources